Key facts
- Inner Cosmos’s last known valuation is $33.0M.
- It has raised $11.9M across 1 recorded rounds; the latest was Seed Round ($1.9M) in Nov 2024.
- Notable investors include Massachusetts Institute of Technology, Deepwater Asset Management, KittyHawk, Brainstorm Ventures, Starlight Ventures — 11 tracked in total.
- Inner Cosmos has filed 1 Form D with the SEC, most recently Nov 2024 ($1.9M sold to 30 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Inner Cosmos
Funding rounds
1 roundsAbout Inner Cosmos
Developer of a brain-computer interface designed to alleviate cognitive disorders. The company's hyper-personalized and precise electricity-based pill gradually rebalances brain networks through accurate sensing and controlled stimulation of the prefrontal cortex using minimally invasive electrical activity, enabling patients and the medical community to reduce excessive reliance on antidepressants and neurological drugs.
- Sector
- Healthcare
- HQ
- Scotts Valley, CA, United States
- Founded
- 2016
- Employees
- 14
- Website
- innercosmos.ai/
- Ownership
- Privately Held (backing)
Inner Cosmos doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inner Cosmos shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inner Cosmos in its N-PORT filings yet. We sweep new filings monthly.